Back to BARCLAYS PLC BARCLAYS PLC

TELOTELO
9 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in TELOMIR PHARMACEUTICALS INC

Yes. Barclays holds 553 shares of TELO (Telomir Pharmaceuticals), worth $708, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$708

Current Shares

553

Total Value Change

-$7,233

Total Shares Change

-1,098

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
553
-
$7080.0%$1.28
17
2026-Q1
Exited
0
-100.0%
$00.0%$1.30
0
2025-Q4
Unchanged
2
0.0%
$30.0%$1.33
0
2025-Q3
Decreased
2
-99.9%
$30.0%$1.39
0
2025-Q2
Decreased
3,017
-85.2%
$3,7720.0%$1.25
0
2025-Q1
Decreased
20,339
-32.1%
$65,6950.0%$3.23
0
2024-Q4
Increased
29,959
+326.9%
$123,4310.0%$4.12
24
2024-Q3
Increased
7,018
+325.1%
$45,0560.0%$6.42
22
2024-Q2
New
1,651
-
$7,9410.0%$4.81
25

Other major holders of TELO: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used